成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook
Chinese English Germany Korean

Shanghai Yifei Biotechnology Co. , Ltd. 企業(yè)の連絡先情報

名前:Shanghai Yifei Biotechnology Co. , Ltd.
電話番號:021-65675885
電子メール:customer_service@efebio.com
國籍:China
ウェブサイト:http://www.efebio.com
商品の合計數(shù):11974
89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

製品カタログ

Br-PEG4-THP1803547-60-5C13H25BrO5
Fentiazacフェンチアザク18046-21-4C17H12ClNO2S
YNT-1851804978-81-1C33H37N5O5S
YNT-185 dihydrochlorideYNT-1851804978-82-2C33H38ClN5O5S
FM041807320-40-6
IACS-010759 hydrochloride1807523-99-4C25H26ClF3N6O4S
TBDMS-PEG4-Acid1807540-77-7C15H32O6Si
CJJ3001807631-83-9C30H33N3
Gedivumab1807954-17-1
Lesofavumab1807960-57-1
Gilvetmab1808081-43-7
Linvencorvir1808248-05-6C29H35FN6O5S
Resomelagon1809420-71-0C14H14N6O2
NS1-IN-1181373-35-3C23H26N2O4
NTRC 0066-01817791-73-3C33H39N7O2
TAK-4181818252-53-7
Anticonvulsant agent 10 HCl1818253-48-3
Cis-22a1819366-84-1C24H30F3N3O2
GlyT1 Inhibitor 11820934-93-7C22H21N5O2
Lorundrostat1820940-17-7C24H33N7O2
ZY-194891821293-40-6C24H32FN9
Tinlarebant1821327-95-0C21H21F5N4O2
N-Nitroso-N-methylaniline-d51821341-18-7C7H8N2O
BRD24921821669-43-5C20H18N4O2
SMO-IN-21822355-27-0C25H25F4N5O2
SDH-IN-21823354-06-8C10H6F3NO
Acloproxalap1824609-67-7C12H14N2O
TRV-120027 acetate (1234510-46-3 free base)1824712-70-0
CXCR2 antagonist 8182498-30-2C14H13N3O5
Smurf-1 modulator CMP Example 201825371-51-4C23H34N4O5
Gatralimab1826020-80-7
Azintuxizumab1826819-57-1
Talacotuzumab1826831-79-1
cPrPMEDAP182798-83-0C11H17N6O4P
Clenoliximab182912-58-9
Idelalisib D51830330-31-8C22H18FN7O
Duvortuxizumab1831098-91-9
Lacnotuzumab1831128-32-5
MLT-9851832576-25-6C17H15Cl2N9O2
L-161240183298-68-2C15H20N2O5
Gantofiban2-[4-[2-[4-[[(5S)-3-[4-[イミノ(メトキシカルボニルアミノ)メチル]フェニル]-2-オキソオキサゾリジン-5-イル]メチル]-1-ピペラジニル]アセチル]-1-ピペラジニル]酢酸エチル183547-57-1C21H29N5O6
Rezivertinib1835667-12-3C27H30N6O3
CXCR2-IN-21838123-21-9C18H23ClN2O5S
NS-2710184220-36-8C22H20N4O
NBI-27914NBI 27914塩酸塩184241-44-9C18H20Cl4N4
Cofrogliptin1844874-26-5C18H19F5N4O3S
(Iso)-Rilmakalim184653-89-2
Diprogulic acidジケグラック18467-77-1C12H18O7
Setrusumab1847394-95-9
Tibulizumab1849636-24-3
Zavondemstat1851412-93-5C26H29N3O3
PF-066492981854061-16-7C16H22O5
PF-067612811854061-19-0C13H17NO6
Iruplinalkib1854943-32-0C29H38ClN6O2P
Cibisatamab1855925-27-7
Tislelizumab1858168-59-8
Basroparib1858179-75-5C18H21F2N7O3
Edralbrutinib1858206-58-2C26H21F2N5O3
Tofimilastトフィミラスト185954-27-2C18H21N5S
Tyrosinase-IN-121860779-42-5C16H12ClN3S
hCYP3A4 Fluorogenic substrate 1186299-00-3C19H12FNO2
PF-067370071863905-38-7C25H28F4N2O6
SU 5616186611-58-5C13H8ClNOS
TriGalNAc CBz186613-57-0C34H35NO11
Cofetuzumab1869928-62-0
(R)-CJ 11974187281-35-2
Loncastuximab1875032-68-0
Naxitamab1879925-92-4
JTV-519 fumarate1883549-36-7C29H36N2O6S
OPC-1678321883747-71-4C21H20ClF3N2O4
Mirikizumabミリキズマブ（遺伝子組換え）1884201-71-1
HDAC8-IN-20a1884231-52-0C15H15NO4
Cbz-B3A1884710-81-9C35H58N6O9
PB1188714-28-5
Dersalazine188913-58-8C35H32N6O4
HS941892594-93-2C15H15N5O2S
Omburtamab1895083-75-6
Aplindore Fumarate189681-71-8C22H22N2O7
Zamaporvint1900754-56-4C21H16F3N7O
Fmoc-aminooxy-PEG2-NH2190249-87-7C19H22N2O5
1,4-Dideoxy-1,4-epithio-D-ribitol190315-43-6C5H10O3S
Mosunetuzumab1905409-39-3
Iladatuzumab1906205-76-2
Enapotamab1912423-61-0
Ursolic aldehydeウルソールアルデヒド19132-81-1C30H48O2
Propionic-2,2-d2 acidプロピオン酸-2,2-D219136-91-5C3H4D2O2
Ezurpimtrostat hydrochloride1914148-73-4C25H32Cl2N4
3-phenylpropanoic-2,2-d2 acidヒドロけい皮酸‐2,2‐D219136-97-1C9H8D2O2
MMPP1895957-18-2C17H18O3
Tisolagiline1894207-44-3C17H17F3N2O
EPZ0332941887195-17-6C20H22ClN7O
EPZ0325971887193-58-9C20H23N7O
EM1271886879-71-5C14H18ClN3O3
FFN 206 dihydrochlorideFFN206二塩酸塩1883548-88-6C12H15ClN2O2
Berberine ursodeoxycholate1868138-66-2
STC314186295-19-2C13H25NaO32S7
(3S,4S)-PF-064599881858291-14-1C19H22ClN7O3
Trifluoromethyl-tubercidin1854086-05-7C12H13F3N4O4
AY 771835734-92-3C21H32N4O4
EGFR-IN-871835666-87-9C28H33N7O2
89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2017 ? ChemicalBook. All rights reserved